Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-09-18 18:06:03 ET · period of report 2026-09-16 · accession 0001835966-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 18:06 | 2026-09-16 | RVMD | Sandler Alan B. | Chief Development Off | S - Sale | $199.24 | -341 | 52.9K | -0.6% | -$67.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | S | D | 5 | $194.96 | 53,204 | D | — | — | (F1) Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 13, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units. (F2) Includes 209 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026. |
| 2 | Common | Common Stock | 2026-09-16 | S | D | 336 | $199.30 | 52,868 | D | — | — | (F1) Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 13, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units. (F3) Includes 52,350 restricted stock units. |